#talc litigation

1 story

#business #earnings #eps decline #johnson and johnson #medtech #money #q3 2026 #revenue growth

JNJ Q3 Earnings Drop Amid Talc Litigation
Johnson & Johnson's Q3 earnings fell as talc litigation costs and medtech slowdown hit.
Seekingalpha · 1m